This program is in collaboration with NIGMS, as well as other secondary institutions including NHGRI, NCI, NIAMS, NICHD, NIDA, NIMH, and OWHR. The program was designed to support multidisciplinary, collaborative research groups to study how genetic variation contributes to interindividual differences in responses to medications. The PGRN includes 14 scientific research projects and seven network resources. The Pharmacogenetics Knowledgebase (PharmGKB) has been established to integrate information obtained from pharmacogenomics, phenotypes, and genotypes. The NHLBI currently supports four studies under this RFA to investigate the pharmacogenetics of heart, lung, and blood diseases and disorders.
The NHLBI Program Officer for PGRN is Dina Paltoo, Ph.D., M.P.H.
NIGMS Pharmacogenomics Research Network
Discover more about PGRN scientists, publications and governing structure.
External Scientific Panel
Members and purpose of PGRN's scientific advisory panel.
Global Alliance for Pharmacogenomics
Learn about partnerships between PGRN and global scientists.
Learn about PharmGKB projects with the scientific community.
View PGRN-related listings from the NIH Guide for Grants and Contracts, the official publication for NIH research grant policies, guidelines, and funding opportunities.
Read PGRN announcements and results.
Find articles and other news coverage featuring PGRN-supported advances.
Scientific Accomplishments and Background of the PGRN
Reach PGRN program staff.
Program Start and End Date
April 2000 to July 2015
Original Funding Announcements (FOA)
Pharmacogenetics Research Network and Knowledge Base
PGRN: Pharmacogenomics Research Network
Last Updated September 2011